DEA Ends Mississippi's Medical Marijuana Research Monopoly

DEA Ends Mississippi's Medical Marijuana Research Monopoly
AP Photo/Andrew Selsky

Countless activists, researchers and enthusiasts let out a collective whimper when the Drug Enforcement Administration upheld a 46-year-old policy of classifying marijuana as a Schedule I narcotic with no medicinal properties.

But then, federal officials did something utterly unexpected and loosened restrictions on the cultivation of marijuana for research purposes. While that might sound counterintuitive, it sends a signal that perhaps the government is looking for a reason to eventually reschedule cannabis as a less offensive drug than, say, heroin.    

Read Full Article »
Comment
Show commentsHide Comments

Related Articles